바이오의약품 첨가제 시장 규모, 점유율, 성장 분석 : 제품별, 기능별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Biopharmaceuticals Excipients Market size was valued at USD 2.43 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 3.97 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global biopharmaceuticals excipients market is witnessing robust growth, driven by the rising demand for biopharmaceutical drugs, increased emphasis on personalized medicine, and notable advancements in biotechnology. The prevalence of chronic conditions, such as cancer and autoimmune diseases, has intensified the need for targeted treatments, elevating the role of specialized excipients in enhancing drug efficacy and reducing side effects. Moreover, the transition towards biologics over traditional small molecules further fuels demand for these excipients. However, the market faces challenges, including a complex regulatory environment that complicates the approval processes and escalates operational costs. Additionally, the high costs associated with manufacturing biopharmaceutical excipients limit broader adoption, given their reliance on advanced technologies and specialized production facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segments Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The growing incidence of chronic illnesses, alongside an expanding elderly demographic, has significantly boosted the demand for biopharmaceutical products. Biologics provide tailored and more efficient treatment options, which in turn heightens the necessity for specialized excipients. These excipients play a crucial role in improving the stability, solubility, and delivery of these complex medications, thereby fueling the expansion of the biopharmaceutical excipients market. As healthcare providers increasingly prioritize effective treatment modalities, the importance of innovative excipients continues to rise, contributing to the overall growth and evolution of this dynamic sector within the biopharmaceutical industry.

Restraints in the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market faces significant constraints due to the stringent and intricate approval processes for biopharmaceutical drugs. The thorough testing and validation requirements for excipients utilized in biologic formulations create obstacles for manufacturers. Navigating through a range of regulatory standards can be quite challenging, which may ultimately impede the growth of the market. As the demand for high-quality excipients increases, manufacturers must ensure rigorous compliance while also innovating, thereby presenting a dual challenge that needs to be addressed to fully capitalize on opportunities within the market landscape.

Market Trends of the Global Biopharmaceuticals Excipients Market

The Global Biopharmaceuticals Excipients market is witnessing a significant trend towards the increased demand for specialty and functional excipients designed to meet the specific needs of biopharmaceutical formulations. As the biologics sector expands and evolves, there is a marked interest in excipients that offer enhanced functionalities, including protein stabilization, controlled drug release mechanisms, and improved solubility. These specialized excipients facilitate the development of more effective and efficient drug delivery systems, driving innovation and supporting the formulation of complex biologic products. This trend reflects the broader shift towards personalized and tailored therapeutics in the biopharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2026-2033)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2026-2033)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2026-2033)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2026-2033)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations